{
  "nctId": "NCT05247853",
  "briefTitle": "HPV Vaccine Effectiveness Study in Rwandan Women Living With HIV",
  "officialTitle": "Long-Term Human Papillomavirus Vaccination Effectiveness and Immunity in Rwandan Women Living With and Without Human Immunodeficiency Virus",
  "protocolDocument": {
    "nctId": "NCT05247853",
    "filename": "Prot_SAP_001.pdf",
    "label": "Study Protocol and Statistical Analysis Plan",
    "date": "2022-06-02",
    "uploadDate": "2024-09-24T10:17",
    "size": 1351228,
    "downloadUrl": "https://clinicaltrials.gov/api/v2/studies/NCT05247853/document/Prot_SAP_001.pdf",
    "hasProtocol": true,
    "hasSap": true,
    "hasIcf": false
  },
  "phase": [],
  "studyType": "OBSERVATIONAL",
  "enrollmentInfo": {
    "enrollmentCount": 3127,
    "enrollmentType": "ACTUAL"
  },
  "timeline": {
    "startDate": "2021-11-03",
    "completionDate": "2025-06-30",
    "primaryCompletionDate": "2023-12-31",
    "firstSubmitDate": "2022-01-13",
    "firstPostDate": "2022-02-21"
  },
  "eligibilityCriteria": {
    "criteria": "Inclusion Criteria:\n\n* Female\n* 18-28 years. The age of inclusion criteria will likely be restricted as age-specific enrollment goals are met.\n* Physically and mentally able and willing to participate in the study.\n* Willing to provide written and signed or thumb printed, informed consent.\n* Known to be living with HIV (i.e., enrolled in a treatment program), or consent to HIV testing to confirm HIV status.\n\nExclusion Criteria:\n\n* Have positive pregnancy test or report to be pregnant at the time of visit or less than 6 weeks post-partum (will be asked to make an appointment 6 or more weeks post-partum)\n* Report to be menstruating at the time of visit (will be asked to make new appointment)\n* History of hysterectomy and no longer have a cervix\n* History of treatment for cervical abnormalities after cervical screening\n* History of cervical cancer\n* Report no previous sexual activity\n* HIV status is unknown, and date of birth is 12/31/1995 or earlier\n* Because this study has age-specific enrollment goals for WLWH and HIV\\[-\\] women, once those enrollment goals are met for each study group, the respective cohorts will be closed and other eligible women will be excluded.",
    "healthyVolunteers": true,
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "maximumAge": "28 Years",
    "stdAges": [
      "ADULT"
    ]
  },
  "endpoints": {
    "primary": [
      {
        "measure": "Change in vaccine effectiveness of prophylactic HPV vaccine",
        "description": "To measure population effectiveness of prophylactic HPV vaccine in reducing cervicovaginal, anal, and/or oral prevalent and 6-12 month persistent infections by HPV6/11/16/18",
        "timeFrame": "Baseline and up to 12 months"
      },
      {
        "measure": "Change in long-term antibody responses to HPV vaccination",
        "description": "To quantify, and examine the determinants of, long-term antibody (into young adulthood) responses to HPV vaccination",
        "timeFrame": "Baseline and up to 12 months"
      }
    ],
    "secondary": [],
    "other": [
      {
        "measure": "Change in HPV natural history study at 6 months",
        "description": "Conduct a natural history study to investigate determinants, including cervicovaginal microbiome (CVM), of short-term HPV persistence in young WLWH and HIV\\[-\\] women living in a SSA setting",
        "timeFrame": "Baseline and 6 months"
      }
    ]
  },
  "complexityMetrics": {
    "eligibilityCriteria": {
      "inclusionCount": 1,
      "exclusionCount": 1,
      "totalCount": 2
    },
    "endpoints": {
      "primaryCount": 2,
      "secondaryCount": 0,
      "otherCount": 1,
      "totalCount": 3
    },
    "studyDesign": {
      "phases": [],
      "isRandomized": false,
      "isMasked": true
    },
    "overallComplexityScore": 41,
    "complexityCategory": "Moderate"
  },
  "collectionDate": "2025-09-22T02:30:41.770Z",
  "dataSource": "ClinicalTrials.gov API v2 - Comprehensive Collection"
}